Search Results 191-200 of 19369 for autoimmune hepatitis
Primary sclerosing cholangitis is a chronic liver disease. It affect the bile ducts in the liver. It's a progressive disease which means it will get worse with ...
See alumni in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D.
The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients ...
Roberts has focused on community-based research with immigrant populations. Three of my four grandparents have succumbed to liver disease related to viral ...
The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
A Study to Evaluate Smartphone-based Digital Phenotyping for Relapse Prediction in Alcohol-associated Liver Disease · Overview · Participation eligibility.
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic runs the Cystic Kidney and Liver Disease Biobank for patient tissue samples.
Liver disease (eg, hepatitis B or C)—Use with caution. ... Autoimmune disorders (eg, Graves' disease, polymyositis, Guillain-Barré syndrome, and autoimmune ...
The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.